======= MIER3 ======= == Gene Information == * **Official Symbol**: MIER3 * **Official Name**: MIER family member 3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=166968|166968]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q7Z3K6|Q7Z3K6]] * **Interactions**: [[https://thebiogrid.org/search.php?search=MIER3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MIER3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/620100|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Transcriptional repressor. {ECO:0000250}. |ELM2| |histone deacetylase activity| |RNA polymerase II repressing transcription factor binding| |histone deacetylation| |protein deacetylation| |protein deacylation| |macromolecule deacylation| |histone deacetylase binding| |transcription corepressor activity| |histone modification| |covalent chromatin modification| |protein-containing complex| |chromatin organization| |negative regulation of transcription by RNA polymerase II| |chromosome organization| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |DNA binding| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |DNA-binding transcription factor activity, RNA polymerase II-specific| |negative regulation of gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp211|AICAR 240μM R05 exp211]]|-2.16| |[[:results:exp349|Cytochalasin-B 5μM R07 exp349]]|-1.98| |[[:results:exp414|Tozasertib 0.1μM R07 exp414]]|-1.92| |[[:results:exp440|Aphidicolin 0.4μM R08 exp440]]|-1.89| |[[:results:exp527|Tanespimycin 14μM R08 exp527]]|-1.86| |[[:results:exp510|Nicotine 3000μM R08 exp510]]|1.7| |[[:results:exp84|UM0125461 0.74μM R02 exp84]]|1.72| |[[:results:exp124|GSK343 3μM R03 exp124]]|1.73| |[[:results:exp30|Rapamycin 10μM R00 exp30]]|1.73| |[[:results:exp79|Q15 2.7μM R02 exp79]]|1.74| |[[:results:exp70|INK128 0.2μM R02 exp70]]|1.75| |[[:results:exp114|A-196 10μM R03 exp114]]|1.76| |[[:results:exp99|NFN1 0.4μM R03 exp99]]|1.77| |[[:results:exp8|Brefeldin A 0.02μM R00 exp8]]|1.78| |[[:results:exp426|FBS-Wisent 0.1 R07 exp426]]|1.82| |[[:results:exp16|DABN 2μM R00 exp16]]|2.02| |[[:results:exp159|Docetaxel 0.001 to 0.002μM on day4 R04 exp159]]|2.02| |[[:results:exp190|Vincristine 0.0005μM R04 exp190]]|2.24| |[[:results:exp340|BN82002 4μM R07 exp340]]|2.42| |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|2.65| |[[:results:exp1|5-Fluorouracil 2μM R00 exp1]]|2.73| |[[:results:exp499|LY2090314 0.003μM R08 exp499]]|2.81| ^Gene^Correlation^ |[[:human genes:b:bcl2l1|BCL2L1]]|0.409| Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 8614 * **Expression level (log2 read counts)**: 6.2 {{:chemogenomics:nalm6 dist.png?nolink |}}